Loading insider details...
Latest Form 4 (Jul 6, 2026): Grant/Award of 134,530 ALLO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 6, 2026 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 134,530 | n/a |
| Feb 4, 2026 | Allogene Therapeutics, Inc. (ALLO) | Sale | 35,700 | $63.2K |
| Jan 23, 2026 | Allogene Therapeutics, Inc. (ALLO) | Sale | 26,269 | $41.0K |
| Feb 5, 2025 | Allogene Therapeutics, Inc. (ALLO) | Sale | 18,832 | $32.0K |
| Jan 29, 2025 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 173,913 | n/a |
| Jan 23, 2025 | Allogene Therapeutics, Inc. (ALLO) | Sale | 27,199 | $48.4K |
| Jan 31, 2024 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 140,000 | n/a |
| Jan 24, 2024 | Allogene Therapeutics, Inc. (ALLO) | Tax Withholding | 24,690 | $78.4K |
| Mar 25, 2023 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 148,035 | n/a |
| Jan 24, 2023 | Allogene Therapeutics, Inc. (ALLO) | Grant/Award | 251,908 | n/a |